Please provide your email address to receive an email when new articles are posted on . A Bay Area neurotechnology firm has announced the commercial release of a novel artificial intelligence-based ...
From "Treatment of Convulsive Status Epilepticus in Children and Adults" Epilepsy Currents 16.1 January/February 2016. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders ...
The choice of drugs for patients with status epilepticus that is refractory to treatment with benzodiazepines has not been thoroughly studied. In a randomized, blinded, adaptive trial, we compared the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback